Increased GLUL expression has been reported as an early marker of hepatocellular carcinoma [21], promoting breast cancer cell proliferation [22], and also found to be an unfavorable prognostic marker in patients with glioblastoma multiforme (GBM) and ovarian cancer [23,24]. The gene discussed is GLUL; the disease is glioblastoma.